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Helicobacter pylori (H. pylori) infection is regarded as the major cause of various gastric diseases (gastritis,
peptic ulcers and gastric cancer) and induces the production of several cytokines. Interleukin-17 (IL-17) is
recently recognized as an important player in the pathophysiology of infectious and immune-mediated
gastrointestinal diseases. H. pylori infection increases IL-17 in the gastric mucosa of humans. IL-17 usually
causes secretion of IL-8 through activation of ERK 1/2 MAP kinase pathway. The released IL-8 attracts
neutrophils promoting inﬂammation. T regulatory cells (Tregs) suppress the inﬂammatory reaction
driven by IL-17, there by favoring bacterial persistence in H. pylori-infection. The pathogenesis of
H. pylori-induced inﬂammation is not well understood. Inﬂammation is promoted by both host factors
and H. pylori factors, such as the proteins cytotoxin associated gene A (cagA) and vacuolating cytotoxin A
(vacA). IL-1b, IL-6, tumor necrosis factor (TNF)-a, TGF-b1, IL-17, IL-18, IL-21 and IL-22 have been reported
to be involved in H. pylori-induced gastric mucosal inﬂammation, but the details and relation to different
patterns of inﬂammation remain unclear. Numerous studies have demonstrated important functions of
IL-17 in acute and chronic inﬂammatory processes. This paper reviews the role of IL-17 in gastritis, peptic
ulcers and gastric cancer related to H. pylori.
© 2015 Elsevier Ltd. All rights reserved.1. Introduction
Helicobacter pylori is a spiral shaped gram-negative ﬂagellate
bacterium that colonizes the antral region of the human stomach.
Approximately half of the world's population is infected with
H. pylori, and the majority of H. pylori-infected patients develop
coexisting chronic gastritis. In most infected patients, H. pylori
colonization does not cause any symptoms such as abdominal pain,
which typically occurs when the stomach is empty during night, or
a few hours after meals, excessive burping, feeling bloated, feeling
sick or vomiting, losing appetite, losing weight and blood or a black
color in feces [1]. However, long-term infection with H. pylori
signiﬁcantly increases the risk of developing site-speciﬁc diseases.
Among infected patients, approximately 10% develop peptic ulcer
disease, 1e3% develop gastric adenocarcinoma, and 0.1% developeh@SKUMS.ac.ir (H. Shirzad).mucosa-associated lymphoid tissue (MALT) lymphoma [2]. The
variable outcomes in H. pylori-infected patients likely depend on
various factors such as virulence factors of H. pylori, inﬂammatory
responses governed by host genetic diversity, or environmental
inﬂuences (such as smoking, malnutrition, high salt intake, vitamin
and antioxidants deﬁciency), which ﬁnally inﬂuence the in-
teractions between pathogen and host [3]. Th17 cells are identiﬁed
as distinct T helper cell populations that play important role in
CD4þ T cell-mediated immunity. In this paper we aimed to review
the interaction of H. pylori and host focusing on biological functions
of IL-17.2. Bacterial virulence factors
Bacterial virulence factors in H. pylori-infected patients play an
important role for the topology and signiﬁcantly increased the risk
of developing site-speciﬁc diseases [4e7]. H. pylori produce a
number of virulence factors that are essential for colonization of the
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best studied bacterial determinants of H. pylori infection are the
presence of cytotoxin-associated gene A (cagA) and vacuolating
cytotoxin A (vacA) genotype. The cagA encodes a high-molecular-
weight immunodominant protein. The cagA gene product is not
itself a virulence factor but is a part of a 40 kb cluster of genes (cag
pathogenicity island), some of which contribute to pathogenicity
[8]. The cagA gene product has been shown to be involved in in-
duction of proinﬂammatory chemokine released by the host cell
[9]. A number of studies in western countries have conﬁrmed that
infection with cagA-positive strains is associated with more severe
gastritis and higher prevalence of peptic ulcer and gastric cancer
[10]. In addition to cagA, the secretion system can also deliver of
H. pylori peptidoglycan in to host cells. In the host intracellular
pattern peptidoglycan interacts with recognition molecule Nod1,
which acts as a sensor for peptidoglycan components originating
from gram-negative bacteria. The interaction of peptidogylcanwith
Nod1 leads to activation of NF-kB-dependent proinﬂammatory
responses, such as secretion of IL-8 or b-defensin-2 [11,12]. Brandt
et al. recently showed that cagA is capable of activating NF-kB,
which in turn induces IL-8 expression [13]. These results show that
H. pylori activates NF-kB through multiple distinct mechanisms.
The vacuolating cytotoxin A (vagA) gene, which is another impor-
tant virulence factor of H. pylori, encodes an 87 kD protein that
induces vacuolation of epithelial cells [14]. The vacA gene is present
in all strains of H. pylori and comprises two variable parts. VacA
gene is present in all strains and comprises 2 variable parts, the s
region (encoding the signal peptide) is present in either the s1 or s2
allele; within type s1, several subtypes (s1a, s1b, and s1c) can be
distinguished [9]. The mosaic combination of s and m region allelic
types determines the production of the cytotoxin and is associated
with pathogenicity of the bacteria [15,16]. As with cagA status,
there are geographic differences between vacA status and the
H. pylori-related diseases. In Western countries infection with vacA
s1 strain is more common in patients with peptic ulcer than in
those with chronic gastritis. However in Asian populations, the
association between vacA diversity and clinical outcome is not
established [17,18]. Another virulence factor is the neutrophil-
activating protein (NAP) of H. pylori that contributes to Th1 polar-
ization by stimulating both IL-12 and IL-23 secretion from neu-
trophils and monocytes [19].
3. Interleukin-17 (IL-17)
IL-17 which belongs to a family of cytokines comprises six
members including IL-17A, IL-17B, IL-17C, IL-17D, IL-17E (IL-25) and
IL-17F [20]. IL-17A which is commonly called IL-17 plays a crucial
role in mammalian immune system. Recently, it was established
that CD4þ T cells that produce IL-17A and IL-17F preferentially
could be generated and that they seem to form a separate lineage of
Th17 cells [21,22]. These cells express retinoic acid-related orphan
receptor gamma-t (RORgt) as a key transcription factor for their
differentiation [23]. In addition to IL-17, these cells may also pro-
duce IL-22 and IL-21 [24]. IL-17 which is a protein of 155 amino
acids is secreted as a glycoprotein with molecular mass of 35 kDa.
Among the members of the IL-17 family there are structural simi-
larities. However, the resemblance of IL-17 is not the same as other
cytokines or structural domains [25]. Among the IL-17 family, IL-
17F possesses the highest homology of amino acid sequence
(60%) to IL-17A [26]. IL-17A and IL-17F might also be secreted as a
heterodimeric IL-17F/A cytokine [27]. IL-17 is able to induce the
production of granulocyte-macrophage colony stimulating factor
(GM-CSF), antimicrobial peptides, endothelial and epithelial cells,
cytokines, chemokines and matrix metalloproteinases from ﬁbro-
blasts. Following bacterial infection, IL-23/IL17 pathway increasesthe recruitment of neutrophils, leading to the extracellular clear-
ance of bacteria [28]. Macrophages and dendritic cells (DCs) at the
early stages of infection produce IL-23 triggering IL-17 response
from tissue-resident T cells. Then, IL-17 acts on endothelial,
epithelial and stromal cells, as well as a subset of monocytes pro-
ducing various pro-inﬂammatory cytokines and chemokines
including TNF-a, IL-1, IL-6, IL-8 and CXC ligand 1 which rapidly
recruit neutrophils to the site of infection [28].
4. Th17, T regulatory cells (Tregs), and H. pylori infection
It has been shown that the expression of the Treg marker Foxp3
in H. pylori infected patients is higher than in uninfected subject
[29,30]. Also Tregs numbers were positively correlated to the
severity of bacterial colonization and TGF-b production [30,31].
Removal of Tregs from the memory T cell pool resulted in enhanced
T cell responses to H. pylori antigens. Tregs may reduce inﬂamma-
tion and tissue destruction, as indicated by the inverse correlation
of their numbers and inﬂammation score [32]. Infected children
with higher level of Foxp3 also reveal low level of gastric pathology
in comparison to adult subjects [33,34]. This may suggest that Tregs
down regulate both immune and inﬂammatory responses in the
gastric mucosa which leads to the persistence of infection. Inter-
estingly, Tregs accumulation was noted close to the lymphoid fol-
licles that are formed in the stomach mucosa during H. pylori
infection, implicating that these cells may be directly induced by
local naive T cells. In humans, the Treg-mediated immune regula-
tion might contribute to H. pylori persistence and adequate Treg
responses in humans is associated with decreased production of
cytokines such as IL-17, IL-6 and IL-23 during H. pylori infection
[30].
Neutralization of IL-10 and TGF-b increases Th17 induction and
decreases Treg induction indicating a negative correlation between
Th17 and Treg generation (Fig. 1). Following the depletion of
CD25þTregs during an acute phase of H. pylori infection caused a
reduction in H. pylori colonization which was correlated with an
increase in H. pylori-speciﬁc Th17, but not Th1 response. These re-
sults may suggest that H. pylorieinduced dendritic cells skew the
Th17/Treg balance toward a Treg-biased response suppressing the
Th17 immunity through a cagA and vacA independent, TGF-b and
IL-10 dependent mechanism [35,36]. In support of these results, it
has been shown that H. pylori is capable of stimulating human
gastric dendritic cells to produce IL-10, potentially supplementing
Treg suppression of inﬂammation in the gastric mucosa [37]. The
H. pylori speciﬁc helper Th17 immunity has been shown to be
suppressed which leads to the persistence of H. pylori in the
stomach.
5. IL-17 and gastritis
H. pylori infection is the main cause of gastric inﬂammation
[38,39]. H. pylori-infected patients develop an antral-predominant
gastritis, which over time progresses to involve the corpus
[40,41]. IL-17 levels have been shown to be increased in the gastric
mucosa of H. pylori-infected patients [42]. This study indicated that
gastric mucosal IL-17 levels in the antrum was increased in
H. pylori-infected patients, especially in the chronic phase of
H. pylori infection. IL-17 mediates the recruitment and activation of
polymorphonuclear neutrophils, a key cellular element in the in-
ﬂammatory lesion associated with H. pylori infection [43]. It has
been shown that during the early stages of H. pylori infection there
is a signiﬁcant rise of IL-17 and IFN-g [44]. Gene expression of IL-6,
IL-12 p35, IL-23 p19, IL-12/IL-23 p40 and transforming growth
factor-b1 (TGF-b1) are all up-regulated inH. pylori-infected subjects
[42,45,46]. IL-12 and IL-23 expressions in the stomach are also
Fig. 1. Role of Th17 cells in H. pylori-infected patients and its correlation with clinical parameters.
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responses, respectively. Therefore, H. pylori infection may induce a
mixed Th17/Th1 cell response contributing to H. pylori colonization
and gastric inﬂammation. Recent studies have shown that adult
H. pylori gastritis is the consequence of both Th17 and Th1 immune-
mediated inﬂammatory pathways and that both pathways are
down regulated in the gastric mucosa of infected children resulting
in lower levels of inﬂammation and ulceration compared with
adults [37]. The study of Joo Hyun et al. inH. pylori-infected patients
with gastritis indicated that a negative correlation between the
Th17 cells/FOXP3þTregs ratio and the bacterial density was
demonstrated in the H. pylori-infected patients with gastritis [34].
6. IL-17 and gastric ulcer
Among infected individuals, approximately 10% develop peptic
ulcer disease. H. pylori infection increases the IL-17 and IL-17 RNA
transcripts in human gastric mucosal and lamina propria mono-
nuclear cells (LPMC) [47]. It has been shown that in gastric LPMC
cultures, neutralization of IL-17 results in a signiﬁcant reduction of
IL-8 secretion. As LPMC and gastric epithelial cells express IL-17
receptors, IL-17 acts on these cells to release IL-8. In patients in
whom the H. pylori is eradicated the IL-17 expression is down-
regulated. Moreover, increased levels of IL-8 and IL-17 are detec-
ted in antral mucosal tissues of gastric ulcer as well as H. pylori-
positive nonulcer patients [48]. It has also been shown that at ulcer
site, IL-17 has higher correlation with the number of neutrophils
and inﬁltrating mononuclear cells. It should be noted that in
H. pylori-infected patients, gastric mucosa is an active site for the
synthesis of both IL-8 and IL-17. Hence, IL-17 in conjunctionwith IL-
8 might be involved in induction of gastric ulcer as IL-8 contributes
to the recruitment of neutrophils at the ulcer site. However, we
should be careful about the axis IL-17/IL-8 since several cytokines
and chemokines are under the control of IL-17. In addition, the
increase in IL-17 and IL-8 seems to be a consequence of the infec-
tion rather than a marker of ulcer or gastritis. Analysis of signaling
pathways associated with the IL-17-induced IL-8 secretion has
revealed that IL-17 activates ERK 1/2 MAP kinases in gastric
epithelial cells isolated from H. pylori-infected patients and in a
gastric epithelial cell line, the effect being more pronounced with
cagA-positive H. pylori strains [49]. Moreover, in the gastric
epithelial cell line, the pharmacologic blockage of this pathway
inhibited IL-8 secretion. The gastric biopsy specimens from
H. pylori-infected patients cultured with a neutralizing IL-17 anti-
body also decreased IL-8 secretion and ERK 1/2 MAP kinaseactivation. There is also a signiﬁcant association in the expression
between IL-8 and IL-17 in H. pylori colonized biopsies.
The chronic inﬂammatory reaction caused by the H. pylori
infection might be involved in the production of reactive oxygen
species (ROS) or reactive nitrogen species (RNS) that in turn may
lead to oxidative DNA damage and apoptosis of gastric epithelial
cells, consequently favoring gastric carcinogenesis and peptic ulcer
[50e52] (Fig. 2). Robinson et al. [53] reported a signiﬁcantly lower
frequency of IL-10(þ) Tregs and enhanced Th1 responses in the
mucosa of patients with peptic ulcer disease, compared to infected
asymptomatic patients. Defective regulation of Tcell responsesmay
lead to the pathogenesis of peptic ulcer disease, as mononuclear
cells from these patients were shown to secrete less IL-10
compared to asymptomatic controls. Also virulence factors of
H. pylori are involved in inducing peptic ulcers. The neutrophil-
activating protein of H. pylori contributes to Th1 polarization by
stimulating both IL-12 and IL-23 secretion from neutrophils and
monocytes [19]. IL-12 production in the gastric mucosa is linked to
the development of peptic ulcers in infection with H. pylori cagþ
strains, most likely due to stimulation of Th1 responses [54]. Also
several studies have associated the cagAþ H. pylori strains with
higher grades of gastric inﬂammation by stimulating the gastric
epithelium to secrete higher levels of pro-inﬂammatory cytokines
and migration and inﬁltration of high levels of mononuclear and
neutrophil cell in the gastric mucosa [55]. These ﬁndings might
indicate that Th17, Th1 populations and virulence factors be
involved in inducing peptic ulcers. The number of Th17 and Th1
cells in patients with peptic ulcer disease is higher than in infected
gastritis patients, also defective Treg responses may lead to the
pathogenesis of peptic ulcer disease [48,53,56].
7. IL-17 and gastric cancer
As H. pylori-induced chronic gastritis plays an important role in
the development of gastric cancer [57], patients with advanced
cancer showed a higher proportion of Th17 cells in peripheral blood
and in tumor-draining lymph nodes compared to non-cancerous
subjects [58,59]. Increased concentrations of IL-17 and IL-23 were
observed in the sera of patients with advanced gastric cancer.
Further, the mRNA expressions of IL-17 and IL-23 p19 in tumor
tissues were signiﬁcantly enhanced. These ﬁndings suggest a close
association of Th17 cells, IL-17, and IL-23 in gastric cancer patho-
genesis. It has been shown that Th17 is inﬁltrated the cancer tis-
sues; TGF-b IL-1b and IL-21 are also included in gastric cancer
development by promoting Th17 cell generation. This may suggest
Fig. 2. Role of Th17 and Th1 cells in H. pylori-infected patients with peptic ulcer. Activation neutrophile and macrophage can lead to important antimicrobial effects but can also
result in inﬂammation and injury due to release of inﬂammatory mediators such as cytokines, reactive oxygen species (ROS), and nitric oxide (NO). Reactive oxygen or nitrogen
species from neutrophils or other inﬂammatory cells increase the oxidative stress that together with other immune-mediated mechanisms, induce apoptosis of the epithelium. In
addition, oxidative stress can damage DNA, leading to the disruption of gene function. Thus, the longer the period of exposure of a tissue to activated immune/inﬂammatory cells
and mediators, the more cellular damage may accumulate.
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cancer development and metastasis [50,60,61]. An increase can be
seen in Th17 in H. pylori-infected patients as ell as in human gastric
tumors. It also has been shown that H. pylori prime GMF (gastric
myoﬁbroblast/ﬁbroblasts) promoted differentiation of Th17. This
process is dependent on TGF-b1, IL-6 and IL-21. H. pylori-exposed
and gastric tumor derived MF (myoﬁbroblast and ﬁbroblast) pro-
duced at increased levels, maintaining a stronger ability to induce
Th17 cells. These ﬁndings suggest that the enhanced Th17 pro-
moting capacity of the GMF (gastric myoﬁbroblast/ﬁbroblasts),
derived from gastric tumors may be among the key factors
contributing to gastric tumor promoting inﬂammatory milieu [60].
A study on the association between gastric cancer and poly-
morphism of IL-17F and IL-17A genes showed that the IL-17A/-197A
allele was signiﬁcantly higher among Japanese patients with gastric
cancer in comparison to control ones [62]. The IL-17A/-197A allele
seems to be associated with the severity of mucosal atrophy of
stomach leading to the development of the intestinal-type gastric
cancer. The homozygote of IL-17A/-197A/A has been associated
with the inﬂammation of gastric mucosa contributing to a small but
signiﬁcant risk for developing diffuse-type gastric cancer. However,
IL-17F/7488C allele is not associated with gastric carcinogenesis.
This allele is associated with inhibition of lymph node metastasis.
An investigation in Chinese patients showed that in gastric cancer
the IL-17F/7488GA and GC genotypes increase the gastric cancer
risks and the IL-17A/197 polymorphism is not associated with
gastric cancer susceptibility [63,64].8. Conclusion
In conclusion, IL-17 may play an important role in the inﬂam-
matory response to H. pylori colonization, and may ﬁnally inﬂuence
the outcome of H. pylori-associated diseases arising within the
context of gastritis. In addition to its ability to enhance IL-8 pro-
duction, IL-17 may modulate the expression of other moleculesrelevant to the pathophysiology of gastritis, peptic ulcer and gastric
cancer. Indeed, the involvement of IL-17 inH. pylori-related gastritis
is also supported by the demonstration that this cytokine is able to
stimulate both immune and non-immune cells to produce multiple
inﬂammatory mediators, such as TNF-a, IL-1, IL-6 and matrix
metalloproteinases [40,65e67]. This cytokines are capable of
causing mucosal degradation and has been associated with
gastrointestinal disease [68,69]. Study in H. pylori-infected patients
with gastritis and peptic ulcer disease indicated that a negative
correlation between the Th17 cells/FOXP3þTregs ratio and the
bacterial density was demonstrated. Tregs may reduce inﬂamma-
tion and tissue destruction, as indicated by the inverse correlation
of their numbers and inﬂammation score [32]. In children with
H. pylori infection, Tregs were found in higher frequencies,
compared to adults, indicating that these cells may protect against
the exaggerated inﬂammation resulting in peptic ulcer disease, as
this complication is rare in this age group [33,37]. In this reviewwe
tried to discuss the relation between IL-17 and Th17 cells to the
clinical forms of H. pylori infection. However, to elucidate further
the signature speciﬁc of IL-17 and Th17 cells to the clinical forms of
H. pylori infection more studies are needed.
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